Vir Biotechnology Inc (VIR)
$10.03
0.19 (1.86%)
3 Undervalued Biotech Gems With 200%+ Analyst Price Targets
These three undervalued biotech stocks have begun garnering investor attention as their treatments show promise.
Top 5 Stocks for 2024
![](https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif)
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
![](https://investorplace.com/wp-content/themes/InvestorPlaceV2/dist/images/analysts_thumb_louis_navellier_new_tiny.jpg)
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
![](https://investorplace.com/wp-content/themes/InvestorPlaceV2/dist/images/analysts_thumb_louis_navellier_new_tiny.jpg)
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
![](https://investorplace.com/wp-content/themes/InvestorPlaceV2/dist/images/analysts_thumb_louis_navellier_new_tiny.jpg)
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
![](https://investorplace.com/wp-content/themes/InvestorPlaceV2/dist/images/analysts_thumb_louis_navellier_new_tiny.jpg)
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
1.34B
PE Ratio
-2.50
EPS
-4.01
Volume (Avg. Vol.)
856,694
Day's Range
$9.98 - $10.43
52-Week Range
$7.61 - $14.45
Dividend & Yield
N/A (N/A)